Novocure Announces 10 Presentations on Simulation Studies Aiming to Optimize Treatment Delivery of Tumor Treating Fields at 22nd Annual Meeting of the Society for Neuro-Oncology
Simulation research supports commitment to advance engineering of Tumor Treating Fields delivery systems
In total, 60 abstracts on Tumor Treating Fields, including two oral presentations, will be presented
The volume of Tumor Treating Fields presentations marks a record number of abstracts for
ST. HELIER, Jersey–(BUSINESS WIRE)–
The 10 presentations include data on a new array layout that could allow delivery of TTFields to infra-tentorial brain tumors, and data showing correlation between TTFields intensity within and surrounding patients’ tumors and their clinical outcomes.
“Our therapy bridges physics and biology, and presents us with the opportunity to make clinical advancements and to advance the engineering of our Tumor Treating Fields delivery systems,” said Dr.
(EXTH-76) Optimizing transducer array configuration for treating tumors in the infratentorial and supratentorial brain using Tumor Treating Fields (TTFields). S. Levi. 7:30 –
(NIMG-66) A method for rapidly creating head models of Glioblastoma patients for studying the delivery of TTFields to the brain. N. Urman. 7:30 –
(EXTH-33) To achieve greater efficacy in tumor-treatment fields: modeling based on the intracellular mechanisms. K.
(NIMG-18) Creating accurate computational head models of patients using dataset combining MRI and CT images. A. Naveh. 7:30 –
(EXTH-22) A new design for transducer arrays for the delivery of Tumor Treating Fields. Z. Bomzon. 7:30 –
(EXTH-04) Guiding principles for predicting the distribution of tumor treating fields in a human brain: A computer modeling study investigating the impact of tumor position, conductivity distribution and tissue homogeneity. A.R. Korshoej. 7:30 –
(RTHP-04) Dosimetric impacts from a tumor treating fields (TTFields) device for glioblastoma multiforme (GBM) patients undergoing simultaneous radiation therapy. T. Li. 5 –
(RTHP-20) Radiation therapy targeting accuracy when combined with alternating electric field therapy. J. Grimm. 5 –
(RTHP-06) End-To-End Workflow for Finite Element Analysis of Tumor Treating Fields in Glioblastomas. J. Timmons. 5 –
(ACTR-91) Numerical simulations of TTFields distribution in patient models reveals a connection between field intensity and patient outcome. N. Urman. 5 –
Headquartered in Jersey,
In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other words and terms of similar meaning. Novocure’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions as well as more specific risks and uncertainties facing
View source version on businesswire.com: http://www.businesswire.com/news/home/20171109005258/en/
Ashley Cordova, 212-767-7558